As of 2024-07-27, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (147.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.90 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -628.3%.
The range of the Relative Valuation is (133.98) - (144.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.9x - 31.8x | 31.3x |
| Forward P/E multiples | 19.6x - 27.9x | 25.6x |
| Fair Price | (133.98) - (144.76) | (147.40) |
| Upside | -580.2% - -618.8% | -628.3% |
| Date | P/E |
| 2024-07-26 | -5.39 |
| 2024-07-25 | -5.46 |
| 2024-07-24 | -5.41 |
| 2024-07-23 | -5.41 |
| 2024-07-22 | -5.40 |
| 2024-07-19 | -5.32 |
| 2024-07-18 | -5.42 |
| 2024-07-17 | -5.55 |
| 2024-07-16 | -5.51 |
| 2024-07-15 | -5.32 |
| 2024-07-12 | -5.24 |
| 2024-07-11 | -5.31 |
| 2024-07-10 | -5.06 |
| 2024-07-09 | -5.02 |
| 2024-07-08 | -4.97 |
| 2024-07-05 | -4.95 |
| 2024-07-03 | -4.89 |
| 2024-07-02 | -5.02 |
| 2024-07-01 | -4.99 |
| 2024-06-28 | -4.89 |
| 2024-06-27 | -4.96 |
| 2024-06-26 | -4.95 |
| 2024-06-25 | -4.97 |
| 2024-06-24 | -5.00 |
| 2024-06-21 | -5.02 |
| 2024-06-20 | -5.01 |
| 2024-06-18 | -5.00 |
| 2024-06-17 | -5.02 |
| 2024-06-14 | -5.07 |
| 2024-06-13 | -5.01 |
| 2024-06-12 | -5.04 |
| 2024-06-11 | -4.99 |
| 2024-06-10 | -4.96 |
| 2024-06-07 | -4.98 |
| 2024-06-06 | -5.06 |
| 2024-06-05 | -5.11 |
| 2024-06-04 | -5.09 |
| 2024-06-03 | -5.15 |
| 2024-05-31 | -4.95 |
| 2024-05-30 | -4.96 |
| 2024-05-29 | -4.95 |
| 2024-05-28 | -4.78 |
| 2024-05-24 | -4.74 |
| 2024-05-23 | -4.77 |
| 2024-05-22 | -4.90 |
| 2024-05-21 | -4.97 |
| 2024-05-20 | -4.95 |
| 2024-05-17 | -4.90 |
| 2024-05-16 | -4.92 |
| 2024-05-15 | -5.03 |